OnKure Therapeutics, Inc.
USD4.17
+0.05 (+1.21%)
CEO
Nicholas A. Saccomano
IPO Date
2021-04-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.00
Prev. Close
$4.12
Day Low
$3.91
Day High
$4.21
52W Low
$1.91
52W High
$5.38
Market Cap
$0.06B
Volume
0.14M
| 303 |
| $4.40 |
| 8 Jun 2026 | Mathers Edward T | director | A-Award | Acquired | 7,650 | $4.30 |
| 8 Jun 2026 | Ratcliffe Liam | director | A-Award | Acquired | 1,275 | $4.30 |
| 8 Jun 2026 | Phillips Andrew John | director | A-Award | Acquired | 7,650 | $4.30 |
| 8 Jun 2026 | Jansen Valerie Malyvanh | director | A-Award | Acquired | 7,650 | $4.30 |
| 8 Jun 2026 | GREY MICHAEL G | director | A-Award | Acquired | 7,650 | $4.30 |
| 8 Jun 2026 | Carruthers R Michael | director | A-Award | Acquired | 7,650 | $4.30 |
| 7 Apr 2026 | AI Biotechnology LLC | 10 percent owner | Disposed | 0 | $0.00 |
| 7 Apr 2026 | AI Biotechnology LLC | 10 percent owner | Disposed | 5,640,222 | $0.00 |